Literature DB >> 9665206

Chronic myeloid leukemia with e19a2 (c3a2) BCR/ABL fusion junction--is it truly a benign disease?

G F How, L T Tan, L C Lim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9665206     DOI: 10.1038/sj.leu.2401055

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Concurrence of e1a2 and e19a2 BCR-ABL1 Fusion Transcripts in a Typical Case of Chronic Myeloid Leukemia.

Authors:  Jaehyeon Lee; Dal Sik Kim; Hye Soo Lee; Sam Im Choi; Yong Gon Cho
Journal:  Ann Lab Med       Date:  2017-01       Impact factor: 3.464

Review 2.  Molecular biology of chronic myeloid leukemia.

Authors:  Y Maru
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

3.  Ponatinib induces a sustained deep molecular response in a chronic myeloid leukaemia patient with an early relapse with a T315I mutation following allogeneic hematopoietic stem cell transplantation: a case report.

Authors:  Nuno Cerveira; Rosa Branca Ferreira; Susana Bizarro; Cecília Correia; Lurdes Torres; Susana Lisboa; Joana Vieira; Rui Santos; Fernando Campilho; Carlos Pinho Vaz; Luís Leite; Manuel R Teixeira; António Campos
Journal:  BMC Cancer       Date:  2018-12-07       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.